profit from every IDR 100 of sales.

PT Metro Healthcare Indonesia Tbk
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
You pay IDR 2,390.00 for every IDR 1 of profit it makes in a year.
of earnings would pay off all its debt.
PT Metro Healthcare Indonesia Tbk vs. similar companies
PT Metro Healthcare Indonesia Tbk grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from IDR 100 of sales | Sales growth a year | Price per IDR 1 of profit |
|---|---|---|---|
PT Metro Healthcare Indonesia Tbk | 2,390.0× · Very expensive | ||
HCA Healthcare | 15.4× · Fair price | ||
Fresenius SE & Co. KGaA | 23.9× · Fair price | ||
IHH Healthcare Berhad | 34.3× · Expensive | ||
Rede D'Or São Luiz | 16.2× · Fair price |
AI analysis
An AI analyst reads PT Metro Healthcare Indonesia Tbk's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 2,390.0×
- –
- –
- 4.4×
- 26.9×
- –
- –
- -1.4%
- 0.0%
- –
Profitability
- 48.9%
- 15.9%
- 1.1%
- –
- 1.6%
- 0.2%
- –
- –
- –
- –
Growth
- +19.1%
- –
- –
- –
- +0.0%
Financial health
- –
- 0.36
- –
- 1.1×
- 0.84
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
News
My wife has dementia and may outlive me. How do we prepare for long-term memory care?MarketWatch · Nov 14, 2026The lonely labor of caregiving: ‘You shouldn’t have to be rich to take care of the people you love’MarketWatch · Nov 14, 2026Electromed targets $1.05M–$1.15M home care revenue per rep as CEO plans April 2027 retirementSeeking Alpha · Nov 11, 2026Medicare used AI to pre-approve patient care, and it immediately led to a large drop in medical servicesMarketWatch · Oct 31, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about PT Metro Healthcare Indonesia Tbk
Is PT Metro Healthcare Indonesia Tbk a good stock to buy?
A business with weak numbers, priced as if everything goes right. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the PT Metro Healthcare Indonesia Tbk AI analysis
What does PT Metro Healthcare Indonesia Tbk do?
PT Metro Healthcare Indonesia Tbk owns, operates, and manages hospitals in Indonesia. It is in Medical Care Facilities.
Is PT Metro Healthcare Indonesia Tbk stock halal?
Yes. PT Metro Healthcare Indonesia Tbk passes our halal screen: its business is permitted and its debt is 9% of its market value, under the 30% limit. How we check
How has PT Metro Healthcare Indonesia Tbk stock done over the past year?
Down 13.6% over the past twelve months, to IDR 356.00. It traded between IDR 298.00 and IDR 850.00 and is 58.1% below its high.
Who are PT Metro Healthcare Indonesia Tbk's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with PT Metro Healthcare Indonesia Tbk's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.



